ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO) Stock Short Interest Report for September

ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO) was the target of a significant decrease in short interest in September. As of September 30th, there was short interest totaling 6,672 shares, a decrease of 50.1% from the September 15th total of 13,369 shares. Approximately 0.2% of the company’s stock are short sold. Based on an average trading volume of 44,566 shares, the short-interest ratio is currently 0.1 days.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of SBIO. Harbor Investment Advisory LLC purchased a new position in shares of ALPS Medical Breakthroughs ETF during the 2nd quarter valued at $29,000. Virtu Financial LLC grew its stake in shares of ALPS Medical Breakthroughs ETF by 7.3% during the 4th quarter. Virtu Financial LLC now owns 17,967 shares of the company’s stock worth $920,000 after acquiring an additional 1,229 shares during the period. Kestra Advisory Services LLC increased its holdings in ALPS Medical Breakthroughs ETF by 27.6% in the 1st quarter. Kestra Advisory Services LLC now owns 8,186 shares of the company’s stock worth $428,000 after acquiring an additional 1,772 shares during the last quarter. Sterling Investment Advisors Ltd. increased its holdings in ALPS Medical Breakthroughs ETF by 8.1% in the 2nd quarter. Sterling Investment Advisors Ltd. now owns 23,800 shares of the company’s stock worth $1,539,000 after acquiring an additional 1,775 shares during the last quarter. Finally, Silver Oak Securities Incorporated increased its holdings in ALPS Medical Breakthroughs ETF by 24.4% in the 1st quarter. Silver Oak Securities Incorporated now owns 16,589 shares of the company’s stock worth $868,000 after acquiring an additional 3,254 shares during the last quarter.

ALPS Medical Breakthroughs ETF Price Performance

Shares of SBIO traded down $0.41 during trading hours on Wednesday, reaching $51.23. The stock had a trading volume of 28,667 shares, compared to its average volume of 38,516. ALPS Medical Breakthroughs ETF has a 12 month low of $41.22 and a 12 month high of $70.85. The firm has a 50-day simple moving average of $63.47 and a 200 day simple moving average of $59.49.

About ALPS Medical Breakthroughs ETF

The ALPS Medical Breakthroughs ETF (SBIO) is an exchange-traded fund that is based on the S-Network Medical Breakthroughs index. The fund tracks, a market-cap weighted index comprising US-listed biotech companies with one or more drugs currently in either Phase II or Phase III FDA clinical trials. SBIO was launched on Dec 31, 2014 and is managed by ALPS.